Skip to main content
OpenTrials
Completed

NCT Number: NCT01346735

Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)

Most literature on ICU infections and the resistant patterns comes from the western literature. This data may not truly reflect the incidence, epidemiology and resistance patterns in developing countries such as India. However, empiric antibiotic therapy is generally initiated using western guidelines. This can potentially lead to inadequate, inappropriate and ineffective empiric antibiotic therapy for ICU infections in the Indian setting. Hence in this multi-center observational study, we seek to:

1. To determine the incidence of ICU-related infections (VAP, CAUTI and CRBSI) in India 2. To explore the microbiology, resistance and treatment patterns of these infections

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ICU stay >48 hours
  • One of the following infections (VAP, CAUTI or CRBSI)

Exclusion criteria

  • Index ICU stay < 48 hours
  • Re-admissions to the ICU within the same hospitalization
  • Age >18 years or <70 years
  • Known HIV serology positivity
  • Burns
  • Solid organ or Bone-marrow transplant
  • No ICU-acquired infections (specifically VAP, CAUTI and CRBSI)

Treatment and study plan

No intervention

Other

Sponsors and collaborators

Lead sponsor

Indian Society of Critical Care Medicine

Other

Registry information

Acronym: MOSER

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
May 3, 2011
Registry last updated
Sep 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.